Clinical Trials

Spiritual Experiences in Interoceptive Training for MOUD: Clinical Implications

A new study explores how spiritual experiences during Mindful Awareness in Body-oriented Therapy (MABT) may support people in medication treatment for opioid use disorder, with implications for adjunctive therapies and psychedelic research.

Published October 29, 2026 Read 3 min 746 words By The Psychedelic Journal Reviewed by Dr. Michael Teplitsky

Spiritual Experiences Emerge in Interoceptive Awareness Training for MOUD

Recent qualitative research published on October 29, 2026 (OpenAlex W7224179780) documents that people receiving medication treatment for opioid use disorder (MOUD) commonly report personalized spiritual experiences during Mindful Awareness in Body-oriented Therapy (MABT). MABT, a structured intervention that develops interoceptive awareness—the conscious perception of internal bodily sensations—was delivered to individuals in MOUD programs. The study found that all participants endorsed some level of spiritual experience, and interoceptive awareness increased from pre- to post-intervention.

Three consistent themes of spiritual experience emerged: Experiencing Wholeness and Healing, Awakening Inner Knowing, and My Body is Nurturing Me. These themes were illustrated through detailed participant narratives, providing qualitative evidence that spiritual and body-oriented approaches may have a role in supporting recovery from opioid use disorder.

Mechanisms: Interoception, Spirituality, and Recovery

Interoceptive awareness and spiritual experiences are increasingly recognized as factors that may support recovery from substance use disorder (SUD), but their interaction has been poorly understood. This study offers direct evidence that training in interoceptive awareness can facilitate spiritual experiences, which in turn may contribute to improved self-care and well-being among people with opioid use disorder.

Neuroscientific research has linked spiritual or 'peak' experiences to brain networks involved in emotion regulation and reward processing—systems often disrupted in SUD. MABT's focus on bodily awareness may help restore these networks by fostering a sense of embodiment and internal safety. The study's finding that spiritual experiences are not only possible but prevalent in this population suggests that body-oriented therapies could be a valuable adjunct to more traditional pharmacological and behavioral treatments.

Notably, the study's approach shares conceptual ground with psychedelic-assisted therapy, where spiritual or mystical-type experiences are frequently reported and sometimes correlated with positive outcomes. However, MABT achieves these effects without the use of psychoactive substances, highlighting a potential pathway for those unable or unwilling to pursue psychedelic interventions.

Implications for Clinical Practice and Psychedelic Research

The integration of spiritual experience and interoceptive awareness into SUD treatment may inform both clinical practice and future research on adjunctive therapies, including psychedelic-assisted interventions. For clinicians, these findings suggest that creating space for spiritual experience within therapy—whether through explicit discussion or body-based practices—could enhance engagement and outcomes for people in MOUD programs.

For researchers, the study underscores the need to further investigate the mechanisms by which interoceptive training and spiritual experience interact to support recovery. This includes exploring how these processes may overlap with or differ from those observed in psychedelic therapy trials. Importantly, the study provides a concrete example of how non-pharmacological interventions can elicit spiritual experiences, offering a control or comparison condition for future randomized trials.

Policy-wise, the findings do not alter existing legal frameworks or access to MOUD or psychedelic therapies. However, they may encourage program designers and regulators to consider the value of integrating body-oriented and spiritual components into SUD treatment protocols, especially as interest in holistic and person-centered care grows.

Risks, Unknowns, and Future Directions

While the study highlights positive experiences and increased interoceptive awareness, several risks and unknowns remain. The sample size and qualitative design limit generalizability, and there is no direct evidence that spiritual experiences alone improve long-term recovery outcomes. Additionally, spiritual experiences can be highly variable and may not be universally beneficial; for some, they could trigger distress or conflict with personal beliefs.

Another open question is whether the mechanisms identified here translate to other populations or settings, including those undergoing psychedelic-assisted therapy. The overlap between interoceptive and spiritual processes is promising but not fully understood. Future research should employ mixed-methods and longitudinal designs to clarify causality and identify which individuals are most likely to benefit from these approaches.

One non-obvious implication is that body-oriented and spiritual interventions like MABT could serve as preparatory or integration tools for individuals considering or completing psychedelic therapy, potentially enhancing safety and efficacy by grounding participants in embodied self-awareness before or after pharmacological sessions.

Looking Forward: Integrating Body, Mind, and Spirit in SUD Treatment

The emergence of spiritual experiences during interoceptive awareness training for people in MOUD programs highlights the potential for holistic, integrative approaches in substance use disorder care. As research into psychedelic-assisted therapy advances, these findings encourage a broader view of recovery—one that values the interplay of body, mind, and spirit, and seeks to harness all available mechanisms for healing.

Byline: Dr. Jamie L. Carter, PhD (Clinical Psychology). How we research: This article was reviewed by Dr. Carter on 2026-11-02, citing primary sources and recent peer-reviewed literature.

Primary source: https://openalex.org/W7224179780 — referenced for fact-checking; this analysis is independent commentary by the The Psychedelic Journal editorial team.
Found this useful?

Get tomorrow's briefing in your inbox

Policy, research, and regulatory signal — delivered on our publish cadence.

Free. No spam. Unsubscribe anytime.